Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy

被引:6
|
作者
Pili-Floury, Sebastien [1 ,2 ,3 ]
Royer, Bernard [4 ,5 ]
Bartholin, Frederique [1 ]
Crumiere, Nathalie [1 ]
Combe, Marielle [1 ]
Chalopin, Jean-Marc [2 ,5 ,6 ]
Pivot, Xavier [2 ,5 ,7 ]
Heyd, Bruno [2 ,5 ,8 ]
Chauffert, Bruno [9 ]
Samain, Emmanuel [1 ,2 ,3 ]
机构
[1] CHU Besancon, Dept Anesthesiol & Intens Care Med, F-25000 Besancon, France
[2] Univ Franche Comte, F-25000 Besancon, France
[3] INSERM IFR 133, EA 3920, F-25000 Besancon, France
[4] CHU Besancon, Dept Pharmacol, F-25000 Besancon, France
[5] INSERM UMR 645, F-25000 Besancon, France
[6] CHU Besancon, Dept Nephrol, F-25000 Besancon, France
[7] CHU Besancon, Dept Oncol, F-25000 Besancon, France
[8] CHU Besancon, Dept Gen Surg, F-25000 Besancon, France
[9] Georges Francois Leclerc Ctr, Dept Oncol, F-21000 Dijon, France
关键词
Ovarian cancer; Intraperitoneal chemotherapy; Cisplatin; Epinephrine; Renal function; CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CHEMOTHERAPY; OVARIAN-CANCER; NEPHROTOXICITY; FAILURE; FEASIBILITY; CARBOPLATIN; MORTALITY; CARCINOMA;
D O I
10.1016/j.ejogrb.2011.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure. Study design: This prospective observational study was carried out on 77 consecutive patients who underwent cisplatin-based IPC procedures, with (n = 23) or without (n = 54) intra-peritoneal epinephrine, for advanced ovarian cancer. Postoperative renal function was assessed using serial serum creatinine measurements and was based on serum creatinine changes from pre-operative values, according to the risk, injury, failure, loss, end-stage kidney disease (RIFLE) classification. Patients were divided into two groups according to postoperative renal function: patients with renal injury or failure (IF group) or patients with no renal alteration or renal risk (NR group). Clinical variables were compared between the IF and NR groups using univariate and multivariate analysis. Results: Postoperative acute change in renal function was observed in 34 (44.2%) patients (unimodal distribution), among whom 23 patients (29.8%) constituted the IF group. In univariate analysis, the absence of epinephrine in the IPC bath, a higher duration of severe hypotension, a lower postoperative blood protein level, and a lower volume of intra-operative diuresis were significantly associated with the occurrence of renal injury or failure. In multivariate analysis, the absence of epinephrine was the only factor associated with the occurrence of moderate to severe acute renal failure (odds ratio [95% confidence interval] = 4.49 [1.36-14.80]). Conclusions: Transient acute renal dysfunction after cisplatin-based IPC associated with cytoreductive surgery is frequent and intra-peritoneal epinephrine plays a protective role. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:199 / 203
页数:5
相关论文
共 47 条
  • [21] Impact of "critical lesions" on outcomes following cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy
    Ben-Yaacov, A.
    Laks, S.
    Goldenshluger, M.
    Nevo, Y.
    Mor, E.
    Schtrechman, G.
    Margalit, O.
    Boursi, B.
    Shacham-Shmueli, E.
    Halpern, N.
    Purim, O.
    Hazzan, D.
    Segev, L.
    Zippel, D.
    Adileh, M.
    Nissan, A.
    EJSO, 2021, 47 (11): : 2933 - 2938
  • [22] Peritoneal Spread of Low-grade Appendiceal Tumours-2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough
    Rao, Apoorva
    Mui, Jasmine
    Barat, Shoma
    Matar, Amer A.
    Alzahrani, Nayef
    Morris, David L.
    ANTICANCER RESEARCH, 2021, 41 (11) : 5569 - 5575
  • [23] Hyperthermic intra-peritoneal chemotherapy (HIPEC) saved by evidence-based medecine: Ovarian carcinomatosis, HIPEC's favorite target?
    Lavoue, Vincent
    Bendifallah, Sofiane
    Collinet, Pierre
    Graesslin, Olivier
    Ballester, Marcos
    Akladios, Cherif
    Carcopino, Xavier
    Bricou, Alexandre
    Koskas, Martin
    Canlorbe, Geoffroy
    Coutant, Charles
    Bolze, Pierre Adrien
    Ouldamer, Lobna
    Darai, Emile
    Touboul, Cyril
    Huchon, Cyrille
    BULLETIN DU CANCER, 2019, 106 (03) : 175 - 178
  • [24] Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel
    Almog Ben-Yaacov
    Eran Nizri
    Guy Lahat
    Yaniv Berger
    Eran Sadot
    Ron Lavi
    Dov Zippel
    Gilbert Sebbag
    Itzhak Avital
    Aviad Hoffman
    Mordechai Gutman
    Ariel Halevy
    Shlomo Schneibaum
    Gur Ben-Ari
    Daniel Benchimol
    Joseph Klausner
    Aviram Nissan
    Indian Journal of Surgical Oncology, 2019, 10 : 19 - 23
  • [25] Intra-Peritoneal Cisplatin Combined with Intravenous Paclitaxel in Optimally Debulked Stage 3 Ovarian Cancer Patients: An Izmir Oncology Group Study
    Unal, Olcun Umit
    Yilmaz, Ahmet Ugur
    Yavuzsen, Tugba
    Akman, Tulay
    Ellidokuz, Hulya
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (15) : 6165 - 6169
  • [26] Scrotal Necrosis Following Heated Intra-peritoneal Chemotherapy: Case Report and Review of the Literature
    Fagih, Samiha N.
    Baghdadi, Rana M.
    Banjer, Aeshah Y.
    Ismail, Amal A.
    Addas, Majda A.
    Shabkah, Alaa A.
    Trabulsi, Nora H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [27] Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy Treatment of Colorectal Peritoneal Metastases: Cohort Analysis of High Volume Disease and Cure Rate
    Cashin, Peter H.
    Dranichnikov, Faoz
    Mahteme, Haile
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (02) : 203 - 206
  • [28] Irradiation Does Not Increase the Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model
    Khosrawipour, Veria
    Bellendorf, Alexander
    Khosrawipour, Carolina
    Hedayat-Pour, Yousef
    Diaz-Carballo, David
    Foerster, Eckart
    Muecke, Ralph
    Kabakci, Burak
    Adamietz, Irenaeus Anton
    Fakhrian, Khashayar
    IN VIVO, 2016, 30 (05): : 593 - 597
  • [29] Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery plus intra-peritoneal chemotherapy
    Singh, Bhavneet
    Singh, Gurkirat
    Alzahrani, Nayef
    Arrowaili, Arief
    Morris, David L.
    EJSO, 2019, 45 (04): : 620 - 624
  • [30] Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery plus intra-peritoneal chemotherapy
    Singh, Bhavneet
    Singh, Gurkirat
    Alzahrani, Nayef
    Morris, David L.
    AMERICAN JOURNAL OF SURGERY, 2020, 219 (04): : 673 - 680